Skip to main content
. 2012 Jun;19(6):865–874. doi: 10.1128/CVI.00119-12

Fig 3.

Fig 3

Diagnostic sensitivity of 20 novel peptides predicted in silico in this study in groups of human serum samples (A) from patients with acute toxoplasmosis (n = 21), (B) from patients with nonactive ocular toxoplasmosis (OT patients) (n = 10), (C) from patients with latent toxoplasmosis (n = 53), and (D) from serologically positive forest workers (n = 100).